Centre d'imagerie moléculaire de Sherbrooke, Department of Nuclear Medicine and Radiobiology, Université de Sherbrooke, 3001, 12th North Avenue Sherbrooke, Qubec, Canada, J1H 5N4.
Bioconjug Chem. 2011 Aug 17;22(8):1729-35. doi: 10.1021/bc2002665. Epub 2011 Jul 29.
Several bifunctional chelates (BFCs) were investigated as carriers of (64)Cu for PET imaging. The most widely used chelator for (64)Cu labeling of BFCs is DOTA (1,4,7,10-tetraazacyclododecane-N,N',N″,N'''-tretraacetic acid), even though this complex exhibits only moderate in vivo stability. In this study, we prepared a series of alternative chelator-peptide conjugates labeled with (64)Cu, measured in vitro receptor binding affinities in human breast cancer T47D cells expressing the gastrin-releasing peptide receptor (GRPR) and compared their in vivo stability in mice. DOTA-, NOTA-(1,4,7-triazacyclononane-1,4,7-triacetic acid), PCTA-(3,6,9,15-tetraazabicyclo[9.3.1]pentadeca-1(15),11,13-triene-3,6,9-triacetic acid), and Oxo-DO3A-(1-oxa-4,7,10-triazacyclododecane-4,7,10-triacetic acid) peptide conjugates were prepared using H(2)N-Aoc-[d-Tyr(6),βAla(11),Thi(13),Nle(14)]bombesin(6-14) (BBN) as a peptide template. The BBN moiety was selected since it binds with high affinity to the GRPR, which is overexpressed on human breast cancer cells. A convenient synthetic approach for the attachment of aniline-BFC to peptides on solid support is also presented. To facilitate the attachment of the aniline-PCTA and aniline-Oxo-DO3A to the peptide via an amide bond, a succinyl spacer was introduced at the N-terminus of BBN. The partially protected aniline-BFC (p-H(2)N-Bn-PCTA(Ot-Bu)(3) or p-H(2)N-Bn-DO3A(Ot-Bu)(3)) was then coupled to the resulting N-terminal carboxylic acid preactivated with DEPBT/ClHOBt on resin. After cleavage and purification, the peptide-conjugates were labeled with (64)Cu using [(64)Cu]Cu(OAc)(2) in 0.1 M ammonium acetate buffer at 100 °C for 15 min. Labeling efficacy was >90% for all peptides; Oxo-DO3A-BBN was incubated an additional 150 min at 100 °C to achieve this high yield. Specific activities varied from 76 to 101 TBq/mmol. Competition assays on T47D cells showed that all BFC-BBN complexes retained high affinity for the GRPR. All BFC-BBN (64)Cu-conjugates were stable for over 20 h when incubated at 37 °C in mouse plasma samples. However, in vivo, only 37% of the (64)Cu/Oxo-DO3A complex remained intact after 20 h while the (64)Cu/DOTA-BBN complex was completely demetalated. In contrast, both (64)Cu/NOTA- and (64)Cu/PCTA-BBN conjugates remained stable during the 20 h time period. Our results indicate that it is possible to successfully conjugate aniline-BFC with peptide on solid support. Our data also show that (64)Cu-labeled NOTA- and PCTA-BBN peptide conjugates are promising radiotracers for PET imaging of many human cancers overexpressing the GRP receptor.
几种双功能螯合剂(BFCs)被研究作为用于 PET 成像的(64)Cu 的载体。用于 BFCs 的(64)Cu 标记的最广泛使用的螯合剂是 DOTA(1,4,7,10-四氮杂环十二烷-N,N',N″,N'''-四乙酸),尽管该络合物仅表现出中等的体内稳定性。在这项研究中,我们制备了一系列用(64)Cu 标记的替代螯合剂-肽缀合物,在表达胃泌素释放肽受体(GRPR)的人乳腺癌 T47D 细胞中测量了体外受体结合亲和力,并比较了它们在小鼠体内的稳定性。DOTA-、NOTA-(1,4,7-三氮杂环壬烷-1,4,7-三乙酸)、PCTA-(3,6,9,15-四氮杂双环[9.3.1]十五烷-1(15),11,13-三烯-3,6,9-三乙酸)和 Oxo-DO3A-(1-氧代-4,7,10-三氮杂环十二烷-4,7,10-三乙酸)肽缀合物使用 H(2)N-Aoc-[d-Tyr(6),βAla(11),Thi(13),Nle(14)] bombesin(6-14)(BBN)作为肽模板进行制备。选择 BBN 部分,因为它与人乳腺癌细胞上过度表达的 GRPR 具有高亲和力结合。还提出了一种在固体载体上连接苯胺-BFC 与肽的方便的合成方法。为了通过酰胺键将苯胺-PCTA 和苯胺-Oxo-DO3A 方便地连接到肽上,在 BBN 的 N-末端引入了琥珀酰基间隔基。然后将部分保护的苯胺-BFC(p-H(2)N-Bn-PCTA(Ot-Bu)(3)或 p-H(2)N-Bn-DO3A(Ot-Bu)(3))与通过 DEPBT/ClHOBt 在树脂上预先活化的所得 N-末端羧酸偶联。在裂解和纯化后,使用 [(64)Cu]Cu(OAc)(2)在 100°C 下在 0.1 M 乙酸铵缓冲液中于 15 分钟内将肽缀合物标记为(64)Cu。所有肽的标记效率均>90%;为了达到这种高收率,Oxo-DO3A-BBN 在 100°C 下再孵育 150 分钟。比活度在 76 到 101 TBq/mmol 之间变化。在 T47D 细胞上的竞争测定表明,所有 BFC-BBN 络合物都保留了对 GRPR 的高亲和力。在 37°C 下在小鼠血浆样品中孵育超过 20 小时时,所有 BFC-BBN(64)Cu 缀合物都保持稳定。然而,在体内,20 小时后只有 37%的(64)Cu/Oxo-DO3A 络合物保持完整,而(64)Cu/DOTA-BBN 络合物完全脱金属。相比之下,(64)Cu/NOTA-和(64)Cu/PCTA-BBN 缀合物在 20 小时的时间段内都保持稳定。我们的结果表明,有可能成功地在固体载体上连接苯胺-BFC 和肽。我们的数据还表明,(64)Cu 标记的 NOTA-和 PCTA-BBN 肽缀合物是用于过表达 GRP 受体的许多人类癌症的 PET 成像的有前途的放射性示踪剂。